Search for: "Blood et al v. Bard et al" Results 1 - 3 of 3
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
FDA Recall Watch
17 Mar 2020, 1:32 pm by Noble McIntyre
LeadCare II, LeadCare Plus, and LeadCare Ultra Blood Lead Tests have been recalled by Magellan Diagnostics, Inc. due to risk of falsely low results. [read post]
Oklahoma Law Blog - http://www.oklahoma-law.com/blog/
IP Think Tank Global Week in Review - 1 August 2008
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
New Jersey Supreme Court Re-affirms Discovery Rule For Statute of Limitations in Pharmaceutical Negligence Lawsuits
3 Mar 2012, 6:48 am by Max Kennerly, Esq.
Hoffman-LaRoche, Inc., et al., which was decided Monday. [read post]
Litigation and Trial - Max Kennerly - http://www.litigationandtrial.com/